BFRI News and Press, Biofrontera Inc. From 09/29/22

WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthc...

WOBURN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that PM360 , a publication for marketing decision makers in the pharmaceutical, bi...

WOBURN, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces the appointment of Gerard DiGirolamo as National Sales Director. In this newly created posit...

German biopharmaceutical company Biofrontera ( NASDAQ: BFRI ) on Tuesday said it had been granted a notice of allowance by the U.S. patent body for a patent covering a nanoemulsion formulation. The U.S. Patent and Trademark Office (USPTO) granted patent application number ...

Company also granted special designation that enables expedited review of a recent U.S. patent application relating to novel PDT illumination protocols WOBURN, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical ...

Are There Any Good Penny Stocks To Buy After The Powell Speech Today? Today was the long-awaited Jackson Hole meeting where Jerome Powell’s speech was followed word-for-word. The stock market was looking for signs and indications of what the future of inflation and rate hikes mig...

WOBURN, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that PM360 , a publication for marketing decision makers in the pharmaceutical, bio...

Biofrontera Inc. (BFRI) Q2 2022 Earnings Conference Call August 12, 2022, 11:00 AM ET Company Participants Tirth Patel - LHA Investor Relations Hermann Lubbert - Executive Chairman Erica Monaco - Chief Executive Officer Conference Call Participants Jo...

Biofrontera press release ( NASDAQ: BFRI ): Q2 GAAP EPS of -$0.05. Revenue of $4.5M (-23.7% Y/Y). As of June 30, 2022, Biofrontera Inc. had cash and cash equivalents of $31.9M, compared with $24.5M as of December 31, 2021. The Company believes its cash and cash equival...

Conference call begins at 11:00 a.m. Eastern time today WOBURN, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today financial results for t...